Rinvoq
FDA Grants New Indication for Rinvoq—Once-Daily Pill for Crohn’s Disease
The FDA granted a new indication for Rinvoq to treat adults with moderate to severe active Crohn’s disease ...
MAY 19, 2023
New Indication Granted to Rinvoq for Active Ankylosing Spondylitis
The FDA granted a new indication to upadacitinib for the treatment of adults with active ankylosing spondylitis who ...
MAY 9, 2022
Rinvoq Now Indicated to Treat Severe Atopic Dermatitis
The FDA granted a new indication for Rinvoq, AbbVie to treat severe atopic dermatitis in adults and children aged ...
JANUARY 18, 2022
FDA Warns of Serious Risks, Including Death, With Tofacitinib
The FDA is requiring the addition of warnings about increased risks for cancer, serious cardiovascular events and ...
SEPTEMBER 3, 2021
Load more